Dr. Sonya Faber

I'm a



I am a scientist and pharmaceutical professional specializing in translational clinical development. Being fortunate to study at top universities, I have worked in research institutes, biotech firms, and clinical operations for several leading pharmaceutical companies. My work in protocol design, medical writing, and project management has included pre-clinical and clinical activities for Phase II and III trials for multiple indications. I am knowledgeable in scientific product development, particularly for neuroscience applications.


Over the course of the last 15 years, I have had the opportunity and privilege to contribute equally to both academic research institutes and commercial pharmaceutical development throughout all stages of the clinical development life-cycle for international clinical research and development.

Brandenberg Gate


An American in Germany
  • Email: email@sonyafaber.com
  • Website: www.SonyaFaber.com
  • Phone: +49-(0)177-263-6895
  • Home: Berlin, Germany
  • Degrees: MA, PhD, MBA
  • Languages: English and German
  • Birthplace: California
  • Nationality: US Citizen

Although I have spent many years working in clinical research, I have always had a passion for teaching and academic research and have used a portion of my energy to continue publishing and research on topics of interest.

See my scholarly works for a complete list of my publications and upcoming papers.

Fast Facts

Clinical Trials managed internationally

Trainings Provided for scientists and clinicians

Papers Under Review hot new research coming soon

Published Papers in peer-reviewed outlets


I am currently employed at Angelini Pharma, headquartered in Rome, Italy, where my work is focused on teaching physicians the mechanism of action and side effects of new medications and the initiation of investigator-initiated studies to treat and diagnose mentally disabled adult epilepsy patients. I also have extensive experience in grant writing, having successfully acquired funding for projects ranging from a 20M € Regenerative Medicine program to public-private partnership funding for the development of diagnostics systems.

Below is an overview of my education and work history. You can also read more about my full employment history and work on clinical trials.

Dr. Faber at ICPR conference


Master of Business Administration

2001 - 2003

BARUCH COLLEGE, Zicklin School of Business, New York, NY

Pharmaceuticals and International Marketing

Doctor of Philosophy

1995 - 2002

NEW YORK UNIVERSITY, Skirball Institute, New York, NY

Developmental Genetics

Master of Arts

1992 - 1995



Post-Baccalaureate Studies

Summer 1992


Neuroscience Research

Bachelor of Arts



Double major in Neurobiology and German Literature

Recent Professional Experience

Adjunct Professor - School of Psychology

2023 - Present


Adjunct Professor - Epidemiology and Public Health

2022 - Present


Medical Science Liaison - Neurology

2020 - Present

ANGELINI PHARMA, Berlin, Germany

Medical Science Liaison - Neurology

2018 - 2020

SYNEOS HEALTH, Berlin, Germany

Site Intelligence and Medical Science Liaison

2016 - 2018

IQVIA, Berlin, Germany

Clinical Trial Lead in Neurology, Oncology, and Rare-Disease Trials

2014 - 2016

COVANCE Clinical & Periapproval Services, Berlin, Germany

Senior Clinical Manager Hematology and Oncology Trials

2013 - 2014


Cofounder, Consultant, and Partner

2011 - 2012

BIOVILLE GmbH, Leipzig Germany

Seminars & Trainings

I am dedicated to training and mentoring the next generation of scientists. I have a special interest in students and clinical researchers and have designed courses to teach scientific writing, research methods, and Good Clinical Practice (GCP). In my current position, I educate physicians about current topics in epilepsy, including organizing medical events, seminars, and symposia.

Most Popular

  • The Ethics of Inclusion: Culturally Informed Research Design
  • Writing the Scientific Paper for Doctoral Students
  • Medical Case Study for Medical Students
  • Stratification and Endpoint Considerations for a Novel Viral Dendritic Cell Combination Therapy
  • Clinical Trials Intensive 3 week Course for Clinical Trial Associates
  • All about Good Clinical Practice, E6 Management Seminar
  • Culturally-Informed Psychedelic Psychotherapy
  • Career Development for Epilepsy Research
  • Understanding Race and Racism
Brandenberg Gate

Main Areas of Interest

Pharmaceutical Development

I am interested in creating innovative solutions for medical conditions to benefit both patients and build knowledge in the scientific community.

Treatments for Epilepsy

As one my main areas of expertise, I coordinate a seminar series for the training and mentoring of young epilepsy researchers and physicians.

Mental Health Disparities

I study the implications of marginalization on the mental health and wellbeing of vulnerable groups.

Biological Racism

I enjoy scientifically debunking antiquated notions about race as a biological construct to make room for more meaningful discussions on the problem of racism in Western society.

Psychedelic Science

I am interested in psychedelic pharmaceuticals and issues related to equity and access of these drugs as they are completing clinical trials and moving into the marketplace.

Diversity & Inclusion in Science

Understanding racial issues and business administration has enabled me to implement equity, diversity, and inclusion initiatives in organizational and academic venues.

Awards & Distinctions

Magna Diagnostics Team won the Germany-wide Landmark “365 Places in the Land of the Ideas" award.

Innovation Competition


Dr. Sonya Faber created the Innovator Circle for the career development of young epilepsy researchers in Frankfurt, Germany.

Innovator Circle


Magna Diagnostics, founded by Dr. Faber, won FutureSax First Place Team award.

Team Award


Dr. Faber was the lead author on a paper about civil courage and racial justice, accepted by the prestigious journal, the American Psychologist.

American Psychological Association


Dr. Sonya Faber is an important voice in the conversation about anti-Black racism in the Western world.

Dr. Williams face

Dr. Monnica Williams